Trulieve Cannabis Corp.
TRLV · XNYSCIK 1754195fmd_1799SEB2YH2ZR370VCJ068Q34JManufacturing · Medicinal Chemicals & Botanical ProductsTemplate: Standard
Coverage: Jan 01, 2018 to Sep 30, 2026, 29 periods
| Line item | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|
| Total revenues | 253 | 522 | 932 | 1,218 | 1,129 | 1,186 | 1,181 |
| Cost of revenue | 61 | 135 | 365 | 529 | 541 | 471 | 470 |
| Gross profit | 192 | 386 | 567 | 689 | 589 | 716 | 711 |
| Selling, general and administrative | 73 | 155 | 311 | 447 | 386 | 510 | 445 |
| Total operating expenses | 79 | 168 | 363 | 639 | 810 | 618 | 568 |
| Operating income | 113 | 218 | 204 | 50 | (222) | 98 | 143 |
| Interest expense | 9 | 20 | 29 | 73 | 82 | 62 | 63 |
| Interest and investment income | – | – | 0 | 2 | 6 | – | – |
| Other non-operating income (expense) | (10) | (61) | (28) | (69) | (63) | (55) | (52) |
| Income before taxes | 104 | 157 | 176 | (19) | (285) | 43 | 91 |
| Income tax expense | 51 | 94 | 146 | 163 | 151 | 198 | 208 |
| Net income from continuing operations | 53 | 63 | 31 | (183) | (436) | (155) | (117) |
| Net income | 53 | 63 | 17 | (253) | (533) | (161) | (122) |
| Net income to common shareholders | 53 | 63 | 18 | (246) | (527) | (155) | (116) |